140 related articles for article (PubMed ID: 33087641)
1. Discovery of C-9 Modified Berberine Derivatives as Novel Lipid-Lowering Agents.
Li DD; Yu P; Xu H; Wang ZZ; Xiao W; Zhao LG
Chem Pharm Bull (Tokyo); 2021 Jan; 69(1):59-66. PubMed ID: 33087641
[TBL] [Abstract][Full Text] [Related]
2. Discovery and structural optimization of 9-O-phenylsulfonyl-berberines as new lipid-lowering agents.
Kong Y; Yi YJ; Liu XQ; Yu P; Zhao LG; Li DD
Bioorg Chem; 2022 Apr; 121():105665. PubMed ID: 35152138
[TBL] [Abstract][Full Text] [Related]
3. Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.
Zhou Y; Cao S; Wang Y; Xu P; Yan J; Bin W; Qiu F; Kang N
Fitoterapia; 2014 Jan; 92():230-7. PubMed ID: 24321576
[TBL] [Abstract][Full Text] [Related]
4. Berberine metabolites exhibit triglyceride-lowering effects via activation of AMP-activated protein kinase in Hep G2 cells.
Cao S; Zhou Y; Xu P; Wang Y; Yan J; Bin W; Qiu F; Kang N
J Ethnopharmacol; 2013 Sep; 149(2):576-82. PubMed ID: 23899453
[TBL] [Abstract][Full Text] [Related]
5. Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs.
Li DD; Yu P; Xiao W; Wang ZZ; Zhao LG
Curr Top Med Chem; 2020; 20(28):2634-2647. PubMed ID: 32901585
[TBL] [Abstract][Full Text] [Related]
6. Predictive QSAR modeling study on berberine derivatives with hypolipidemic activity.
Yu P; Li D; Ni J; Zhao L; Ding G; Wang Z; Xiao W
Chem Biol Drug Des; 2018 Apr; 91(4):867-873. PubMed ID: 29143468
[TBL] [Abstract][Full Text] [Related]
7. Combination of Berberine with Resveratrol Improves the Lipid-Lowering Efficacy.
Zhu X; Yang J; Zhu W; Yin X; Yang B; Wei Y; Guo X
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563192
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 7,9-Disulfatetrahydroberberine as Novel Lipid-Lowering Agents.
Li DD; Yu P; Wang ZZ; Xiao W; Zhou XH; Zhao LG
ACS Omega; 2020 Dec; 5(48):30836-30848. PubMed ID: 33324793
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and lipid-lowering activities of penipyridone derivatives.
Li L; Duan Z; Bai D; Lu F; Hao J; Zhu T; Li D
Bioorg Med Chem; 2021 Jun; 40():116192. PubMed ID: 33965838
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota specifically mediates the anti-hypercholesterolemic effect of berberine (BBR) and facilitates to predict BBR's cholesterol-decreasing efficacy in patients.
Wu C; Zhao Y; Zhang Y; Yang Y; Su W; Yang Y; Sun L; Zhang F; Yu J; Wang Y; Guo P; Zhu B; Wu S
J Adv Res; 2022 Mar; 37():197-208. PubMed ID: 35499044
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship of berberine analogues in LDLR up-regulation and AMPK activation.
Wang YX; Kong WJ; Li YH; Tang S; Li Z; Li YB; Shan YQ; Bi CW; Jiang JD; Song DQ
Bioorg Med Chem; 2012 Nov; 20(22):6552-8. PubMed ID: 23058107
[TBL] [Abstract][Full Text] [Related]
12. Combination of simvastatin with berberine improves the lipid-lowering efficacy.
Kong WJ; Wei J; Zuo ZY; Wang YM; Song DQ; You XF; Zhao LX; Pan HN; Jiang JD
Metabolism; 2008 Aug; 57(8):1029-37. PubMed ID: 18640378
[TBL] [Abstract][Full Text] [Related]
13. The study on synthesis and vitro hypolipidemic activity of novel berberine derivatives nitric oxide donors.
Wang K; Li Z; Zhang W; Liu Y; Wang X; Sun M; Fang X; Han W
Fitoterapia; 2024 Jul; 176():105964. PubMed ID: 38663561
[TBL] [Abstract][Full Text] [Related]
14. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
[TBL] [Abstract][Full Text] [Related]
15. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
16. [Synthesis and biological evaluation of tetrahydrocoptisine quaternary ammonium compounds].
Wang DM; Wei JZ; Fan BY; Liu Q; Zhu HB; Shen ZF; Wu S
Yao Xue Xue Bao; 2012 Dec; 47(12):1640-5. PubMed ID: 23460970
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine.
Brusq JM; Ancellin N; Grondin P; Guillard R; Martin S; Saintillan Y; Issandou M
J Lipid Res; 2006 Jun; 47(6):1281-8. PubMed ID: 16508037
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological activity of 9-
Kong Y; Xing QQ; Tian YX; Li L; Yu P; Zhao LG; Li DD
Nat Prod Res; 2023; 37(20):3452-3460. PubMed ID: 35695154
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and cholesterol-lowering efficacy for prodrugs of berberrubine.
Li YH; Li Y; Yang P; Kong WJ; You XF; Ren G; Deng HB; Wang YM; Wang YX; Jiang JD; Song DQ
Bioorg Med Chem; 2010 Sep; 18(17):6422-8. PubMed ID: 20673726
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anticancer Activity of 9-O-Pyrazole Alkyl Substituted Berberine Derivatives.
Xiao D; He F; Peng D; Zou M; Peng J; Liu P; Liu Y; Liu Z
Anticancer Agents Med Chem; 2018; 18(11):1639-1648. PubMed ID: 30014806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
